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LETTERS TO THE EDITOR
Colonic epithelial metabolism in ulcerative colitis EDITOR,-The paper by Drs Finnie, Taylor, and Rhodes (published in this issue of Gut) is an important contribution to the study of colonic mucosal metabolism, now evaluated by colonic biopsy specimens containing both epithelial cells and laminal immune cells, rather than isolated colonic epithelial cells devoid of immune cells. Unfortunately the current method and isolated cell system previously reported' have not been compared with regard to metabolic performance.
The results of the biopsy technique are somewhat at variance with findings that we and others"' have made. The study by Finnie et al shows: (a) concentration of 5 mmol/I of butyrate to have an adverse effect on mucosal tissue; (b) no changes of butyrate oxidation have been found in ulcerative colitis compared with controls; and (c) no significant glutamine utilisation was found in lymphocytes that are known to utilise glutamine.5 These are important metabolic differences, which are puzzling but for which some explanation comes to mind. Butyrate metabolism in biopsy specimens may have been (a) suboptimal as dithiothreitol, which universally increases oxygen consumption' was not present in the incubation medium; (b) the degree of radioactivity was considerably 'hotter' with biopsy specimens than isolated cells: radioactive swamping comparative with weight of epithelial cells may therefore have produced an unsatisfactory precursor product relation6; (c) despite current findings on circulating lymphocytes, laminal immune cells particularly those in ulcerative colitis would be metabolically more activated in ulcerative colitis cases than control cases5 and these may have affected patterns of substrate metabolism. The great advantage of isolated epithelial cells is that they contain almost no immune cells, which usually will display some metabolic activity in the biopsy method.
Therapeutically butyrate has been beneficially used in humans at a concentration of 100 We feel it is very unlikely that the increased metabolism of glutamine in ulcerative colitis is the result of metabolism by inflammatory cells. It is not correct to say that our technique failed to show any metabolism of glutamine by lymphocytes. When lymphocytes were added to mucosal samples in numbers roughly equivalent to those likely to be present in excess in inflamed mucosa there was an increase in metabolism from (mean (SD)) 4-5 (1-6) nmol/4tg protein/h to 5-5 (2 2) but this was not statistically significant. In parallel studies not included in the paper five aliquots each of I-l X 106 lymphocytes studied alone showed glutamine metabolism equivalent to 1-2 (1 1) (mean (SD)) nmol/h using the same method. The number of lymphocytes in a biopsy specimen is likely to be far outweighed by the number of epithelial cells, however,3 and the metabolism of glutamine is greater in the second.4 Although Ardawi and Newsholme suggested that glutamine metabolism by lymphocytes could increase during proliferation5 they suggested that the same could also apply to colonocytes.4
Although the amount of radioactivity used in our study (1 ,uCi for 10 mg tissue) was about eight times greater per unit weight of tissue than Roediger used (0 25 ,utCi for 5 mg tissue=20 mg dry weight), up to 5% of the [14C butyrate] was retrieved as '4C05, and this is a reasonable indication that 'swamping' did not occur.
The response of ulcerative colitis to rectal butyrate suggests that the epithelium is able to use this effectively as a substrate in ulcerative colitis, and whether 100 ml of a 100 mM butyrate enema exposes epithelial cells to a concentration that is closer to the one we used (1 mM) in tissue culture or that used by Roediger (10 mM) in cell culture is not known. At acid pH 850 mM sodium butyrate has been shown to be considerably colitogenic in mice.6
We agree that the isolated cell model has potential advantages over our system, but suspect that these advantages may be outweighed by the potential problem of inflicting damage upon cells during their isolation. Further studies comparing the two methods are warranted; but these should ideally be carried out in quiescent ulcerative colitis in which case a technique for studying cells isolated from biopsy specimens will need to be evaluated. The poor treatment response to sucralfate (47%) obtained in Bianchi Porro's study is in apparent disagreement with our earlier, uncontrolled report of an 81% success rate with that anti-ulcer agent in refractory duodenal ulcers.4 Of course, at that time, virtually nothing was
